Going to Market in Healthcare: B2C2B
Raising Health
00:00
BioEats World - A16Z Podcast
I wasn't part of it but I am certain that the tens of thousands of clinicians who raised their own costs that they wanted this device before was available helped drive confidence in the process. You know, at the point where we were going public, we were just really starting that enterprise of market shift. There was data points around the increased lifetime value of the enterprise customer right higher SaaS revenue and lower churn to be expected there. The enterprise story was attractive and different because most med device companies do not have a large software business. Time to not be good at it is very cool.
Play episode from 32:48
Transcript
